Works matching IS 17555930 AND DT 2017 AND VI 23 AND IP 11
Results: 7
Fibroblast growth factor 22 is a novel modulator of depression through interleukin-1β.
- Published in:
- CNS Neuroscience & Therapeutics, 2017, v. 23, n. 11, p. 907, doi. 10.1111/cns.12760
- By:
- Publication type:
- Article
miR-181d-5p promotes neurite outgrowth in PC12 Cells via PI3K/Akt pathway.
- Published in:
- CNS Neuroscience & Therapeutics, 2017, v. 23, n. 11, p. 894, doi. 10.1111/cns.12761
- By:
- Publication type:
- Article
Increased adult neurogenesis associated with reactive astrocytosis occurs prior to neuron loss in a mouse model of neurodegenerative disease.
- Published in:
- CNS Neuroscience & Therapeutics, 2017, v. 23, n. 11, p. 885, doi. 10.1111/cns.12763
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- CNS Neuroscience & Therapeutics, 2017, v. 23, n. 11, p. 851, doi. 10.1111/cns.12645
- Publication type:
- Article
Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ.
- Published in:
- CNS Neuroscience & Therapeutics, 2017, v. 23, n. 11, p. 855, doi. 10.1111/cns.12757
- By:
- Publication type:
- Article
Activating α7 nicotinic acetylcholine receptor inhibits NLRP3 inflammasome through regulation of β-arrestin-1.
- Published in:
- CNS Neuroscience & Therapeutics, 2017, v. 23, n. 11, p. 875, doi. 10.1111/cns.12758
- By:
- Publication type:
- Article
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy.
- Published in:
- CNS Neuroscience & Therapeutics, 2017, v. 23, n. 11, p. 866, doi. 10.1111/cns.12759
- By:
- Publication type:
- Article